Cargando…

Changes in clinical features of multiple system atrophy in Japan

INTRODUCTION: Multiple system atrophy (MSA) is an adult-onset progressive neurodegenerative disease that causes parkinsonism, cerebellar ataxia, and/or autonomic failure. MSA is categorized as MSA with predominant cerebellar ataxia (MSA-C) or MSA with predominant parkinsonism (MSA-P) according to th...

Descripción completa

Detalles Bibliográficos
Autores principales: Tokuhara, Yusuke, Watanabe, Shohei, Yoshikawa, Hiroo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298761/
https://www.ncbi.nlm.nih.gov/pubmed/34316637
http://dx.doi.org/10.1016/j.prdoa.2020.100054
_version_ 1783726120378564608
author Tokuhara, Yusuke
Watanabe, Shohei
Yoshikawa, Hiroo
author_facet Tokuhara, Yusuke
Watanabe, Shohei
Yoshikawa, Hiroo
author_sort Tokuhara, Yusuke
collection PubMed
description INTRODUCTION: Multiple system atrophy (MSA) is an adult-onset progressive neurodegenerative disease that causes parkinsonism, cerebellar ataxia, and/or autonomic failure. MSA is categorized as MSA with predominant cerebellar ataxia (MSA-C) or MSA with predominant parkinsonism (MSA-P) according to the cardinal symptom at diagnosis. MSA-C has been reported to be the predominant presentation in Japan to date. However, major epidemiological studies regarding MSA in Japan were carried out before 2006; thus, the recent advancement of various imaging studies remains unclear. This study aimed to investigate the clinical characteristics of the recent MSA patients in Japan. METHODS: In this retrospective study, we divided 80 probable MSA patients into group A and group B and examined them to reveal whether the clinical features of MSA were different depending on the time periods of diagnosis (1989–2003 and 2004–2018, respectively). RESULTS: The age at onset was significantly higher in MSA-P patients than in MSA-C patients (p = 0.0039) and was also higher in group B than in group A (p = 0.013). Although MSA-C was the predominant type in both groups, MSA-P was significantly more frequent in group B than in group A (p = 0.039). Although not statistically significant, the early heart/mediastinum ratio in [(123)I]-meta-iodo benzylguanidine (MIBG) myocardial scintigraphy tended to be lower in patients with MSA-P than in those with MSA-C. CONCLUSION: The proportion of MSA-P was likely larger than previously recorded due to the aging population in Japan and the improvement of differential diagnosis between PD and MSA-P.
format Online
Article
Text
id pubmed-8298761
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-82987612021-07-26 Changes in clinical features of multiple system atrophy in Japan Tokuhara, Yusuke Watanabe, Shohei Yoshikawa, Hiroo Clin Park Relat Disord Original Article INTRODUCTION: Multiple system atrophy (MSA) is an adult-onset progressive neurodegenerative disease that causes parkinsonism, cerebellar ataxia, and/or autonomic failure. MSA is categorized as MSA with predominant cerebellar ataxia (MSA-C) or MSA with predominant parkinsonism (MSA-P) according to the cardinal symptom at diagnosis. MSA-C has been reported to be the predominant presentation in Japan to date. However, major epidemiological studies regarding MSA in Japan were carried out before 2006; thus, the recent advancement of various imaging studies remains unclear. This study aimed to investigate the clinical characteristics of the recent MSA patients in Japan. METHODS: In this retrospective study, we divided 80 probable MSA patients into group A and group B and examined them to reveal whether the clinical features of MSA were different depending on the time periods of diagnosis (1989–2003 and 2004–2018, respectively). RESULTS: The age at onset was significantly higher in MSA-P patients than in MSA-C patients (p = 0.0039) and was also higher in group B than in group A (p = 0.013). Although MSA-C was the predominant type in both groups, MSA-P was significantly more frequent in group B than in group A (p = 0.039). Although not statistically significant, the early heart/mediastinum ratio in [(123)I]-meta-iodo benzylguanidine (MIBG) myocardial scintigraphy tended to be lower in patients with MSA-P than in those with MSA-C. CONCLUSION: The proportion of MSA-P was likely larger than previously recorded due to the aging population in Japan and the improvement of differential diagnosis between PD and MSA-P. Elsevier 2020-04-22 /pmc/articles/PMC8298761/ /pubmed/34316637 http://dx.doi.org/10.1016/j.prdoa.2020.100054 Text en © 2020 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Original Article
Tokuhara, Yusuke
Watanabe, Shohei
Yoshikawa, Hiroo
Changes in clinical features of multiple system atrophy in Japan
title Changes in clinical features of multiple system atrophy in Japan
title_full Changes in clinical features of multiple system atrophy in Japan
title_fullStr Changes in clinical features of multiple system atrophy in Japan
title_full_unstemmed Changes in clinical features of multiple system atrophy in Japan
title_short Changes in clinical features of multiple system atrophy in Japan
title_sort changes in clinical features of multiple system atrophy in japan
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298761/
https://www.ncbi.nlm.nih.gov/pubmed/34316637
http://dx.doi.org/10.1016/j.prdoa.2020.100054
work_keys_str_mv AT tokuharayusuke changesinclinicalfeaturesofmultiplesystematrophyinjapan
AT watanabeshohei changesinclinicalfeaturesofmultiplesystematrophyinjapan
AT yoshikawahiroo changesinclinicalfeaturesofmultiplesystematrophyinjapan